NEJM February 2026 Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges

This Week In Medicine · Feb 26, 2026 · 12m

This study investigates whether a long-acting injectable treatment is more effective than traditional daily pills for HIV patients who struggle with medication adherence. Researchers compared a monthly regimen of cabotegravir and rilpivirine against standard oral therapy in a group of participants who previously had difficulty maintaining low viral levels. The trial was halted early because the injectable method proved significantly superior, resulting in a much lower rate of treatment failure compared to the oral alternative. Ultimately, the findings suggest that moving away from daily pills…